Back to search

Article

Covid 19 Infection in Patients with Rheumatic Immune-Mediated Diseases in a Single University Hospital. Matched Case-Control Study and Literature Review.

2022-08-31

Abstract excerpt

<h4>Background: </h4> COVID19 may present different degrees of severity. Viral infections in patients with rheumatic inflammatory diseases (R-IMID) tend to present more severe disease. However, data comparing the severity of the disease between R-IMID and the general population are scarce. <h4>Objectives: </h4> To compare predisposing factors, clinical, serological features, and severity of COVID-19 infection in p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d9a6e596-8669-5cdc-b3d7-aa2a9cb7e414
DOI
10.21203/rs.3.rs-1987049/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Covid 19 Infection in Patients with Rheumatic Immune-Mediated Diseases in a Single University Hospital. Matched Case-Control Study and Literature Review.DOI 10.21203/rs.3.rs-1987049/v1
UNVACCINATED PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES HAVE HETEROGENEOUS AND UNRELATED RISKS OF COVID INFECTION AND POOR OUTCOMESemantic proximity
No Increased Lethality in Covid-19 in Patients with Inflammatory Rheumatic Diseases Compared to the General Population - a Comparison of Two German Registries -Semantic proximity
ReumaCoV Brasil Registry: Brazilian Study of Patients with Immuno-mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2&nbsp;Semantic proximity
Clinical Features of Rheumatic Patients with Biologics Treatment Infected with COVID-19 in ChinaSemantic proximity
Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in ScotlandSemantic proximity
Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort StudySemantic proximity
Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugsSemantic proximity
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort studySemantic proximity
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to OmicronSemantic proximity
A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic DiseasesSemantic proximity
How Did COVID-19 Pandemic Affect Rheumatology Out-Patients Practice? A Single-Center Experience from TurkeySemantic proximity
An Investigation of COVID-19 Infection in Patients with Polymyalgia RheumaticaSemantic proximity
Select a neighboring publication to make it the new centre.